Tonix Pharmaceuticals (TNXP) News Today $28.37 +0.66 (+2.38%) Closing price 04:00 PM EasternExtended Trading$28.30 -0.07 (-0.25%) As of 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TNXP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Tonix Pharma Completes FDA Meeting for TNX-102 SLSeptember 18 at 8:31 AM | tipranks.comTonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive DisorderSeptember 18 at 8:00 AM | globenewswire.comTonix Pharmaceuticals announces in-licensing of worldwide rights to TNX-4800September 17 at 5:13 PM | msn.comTonix Pharmaceuticals In-Licenses TNX-4800 for Lyme Disease Prevention Following Positive Phase 1 Study ResultsSeptember 17 at 7:50 AM | quiverquant.comQTonix Pharma Licenses Rights to Lyme Disease AntibodySeptember 17 at 7:30 AM | tipranks.comTonix Pharmaceuticals Announces In-licensing Phase 2/3-Ready Monoclonal Antibody Designed for Seasonal Prevention of Lyme Disease (TNX-4800)September 17 at 7:00 AM | globenewswire.comTonix Pharmaceuticals presents clinical data on Tonmya at PAINWEEKSeptember 9, 2025 | msn.comTonix Pharmaceuticals Presents Clinical Data on Tonmya™ for the Treatment of Fibromyalgia at PAINWEEK 2025September 8, 2025 | globenewswire.comThree new option listings and one option delisting on September 4thSeptember 4, 2025 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Cross Above 200-Day Moving Average - Should You Sell?September 4, 2025 | marketbeat.comTonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025August 28, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Cross Above 200-Day Moving Average - Time to Sell?August 28, 2025 | marketbeat.comCarolyn Taylor Buys 418 Shares of Tonix Pharmaceuticals (NASDAQ:TNXP) StockAugust 22, 2025 | insidertrades.comSA analyst upgrades/downgrades: HD, AAPL, TMUS, TNXPAugust 20, 2025 | msn.comTonix Pharma Announces FDA Approval of TonmyaAugust 19, 2025 | msn.comTonix Pharmaceuticals Soars, Then Sinks: What's Next After Tonmya's Approval (Upgrade)August 19, 2025 | seekingalpha.comTonix Pharmaceuticals Reports Q2 2025 Financial ResultsAugust 19, 2025 | msn.comFDA Approves New Fibromyalgia Drug, But Tonix Shares SlideAugust 18, 2025 | msn.comTonix Pharma's Drug Gets FDA Nod For Chronic Pain Condition, First New Therapy In Over 15 YearsAugust 18, 2025 | finance.yahoo.comTonix Pharmaceuticals (TNXP) Faces Volatility Despite FDA ApprovalAugust 18, 2025 | gurufocus.comFDA Approves New Fibromyalgia Drug, Tonix Shares ClimbAugust 18, 2025 | msn.comThis Pharma Stock Shot Up 4% Pre-Market After FDA Approval For Drug, Retail’s Super Bullish But Believes ‘This Is A Marathon, Not A Sprint’August 18, 2025 | msn.comTonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) Stock Holdings Reduced by Virtu Financial LLCAugust 18, 2025 | marketbeat.comNoble Financial Has Pessimistic Outlook of TNXP Q3 EarningsAugust 17, 2025 | marketbeat.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Gap Up - Time to Buy?August 16, 2025 | marketbeat.comTonix Secures Fibromyalgia Approval - What Investors Should KnowAugust 16, 2025 | seekingalpha.comTonix Pharma Gains FDA Approval for TonmyaAugust 16, 2025 | msn.comTonix Pharmaceuticals jumps 17% to $60.13 after FDA approval of TonmyaAugust 15, 2025 | msn.comTonix Pharmaceuticals stock halted ahead of FDA approval newsAugust 15, 2025 | investing.comForm 8K Tonix Pharmaceuticals Holding Corp For: 15 AugustAugust 15, 2025 | investing.comTonix Pharmaceuticals (TNXP) Secures FDA Approval for Fibromyalgia DrugAugust 15, 2025 | gurufocus.comTonix Pharmaceuticals Announces FDA Approval of Tonmya, the First New Fibromyalgia Therapy in Over 15 YearsAugust 15, 2025 | quiverquant.comQUS FDA approves Tonix Pharma's drug to manage pain related to chronic conditionAugust 15, 2025 | reuters.comTonix Pharmaceuticals Announces FDA Approval of Tonmya™ (cyclobenzaprine HCl sublingual tablets) for the Treatment of FibromyalgiaAugust 15, 2025 | globenewswire.comTonix Pharma Gears Up For Key FDA Decision Today, Stock Up Over 500% In 5 Months August 15, 2025 | rttnews.comCompanies Like Tonix Pharmaceuticals Holding (NASDAQ:TNXP) Are In A Position To Invest In GrowthAugust 14, 2025 | finance.yahoo.comWhat's Going On With Tonix Pharmaceuticals (TNXP) Stock?August 14, 2025 | benzinga.comCaitong International Asset Management Co. Ltd Takes $405,000 Position in Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)August 14, 2025 | marketbeat.comTonix Pharma: Eyes On FDA Deadline This Friday, I See A 65% Approval PotentialAugust 13, 2025 | seekingalpha.comWhy Tonix Pharmaceuticals (TNXP) Stock Is Climbing This WeekAugust 13, 2025 | benzinga.comTonix Pharma Scores Best Day Since March On Hopes For First New Fibromyalgia Drug Approval in 16 Years; Retail’s OptimisticAugust 13, 2025 | msn.comTonix Pharmaceuticals (NASDAQ:TNXP) Posts Quarterly Earnings Results, Beats Estimates By $2.85 EPSAugust 12, 2025 | marketbeat.comTonix Pharmaceuticals Reports Q2 2025 EPS Loss of $3. ...August 12, 2025 | gurufocus.comTonix Pharmaceuticals (TNXP) Stock Surges On Q2 Earnings Beat And Upcoming FDA CatalystAugust 12, 2025 | benzinga.comTonix Pharmaceuticals Holding Corp.: Tonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational HighlightsAugust 12, 2025 | finanznachrichten.deTonix Pharmaceuticals Reports Financial Results and Highlights PDUFA Goal Date for TNX-102 SL in Fibromyalgia TreatmentAugust 11, 2025 | quiverquant.comQTonix Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational HighlightsAugust 11, 2025 | globenewswire.comTonix Pharmaceuticals (NASDAQ:TNXP) Shares Pass Above 200-Day Moving Average - What's Next?August 9, 2025 | marketbeat.comTonix Pharmaceuticals (TNXP) Expected to Announce Earnings on FridayAugust 8, 2025 | marketbeat.comWhat is Zacks Small Cap's Estimate for TNXP Q2 Earnings?August 1, 2025 | marketbeat.com Get Tonix Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNXP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. TNXP Media Mentions By Week TNXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNXP News Sentiment▼-0.500.63▲Average Medical News Sentiment TNXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNXP Articles This Week▼66▲TNXP Articles Average Week Get the Latest News and Ratings for TNXP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Tonix Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Maze Therapeutics News Pharming Group News ARS Pharmaceuticals News atai Life Sciences News Cronos Group News Upstream Bio News CorMedix News Spyre Therapeutics News uniQure News Arbutus Biopharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNXP) was last updated on 9/18/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tonix Pharmaceuticals Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tonix Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TNXP Stock Alerts